PDB8 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Insulin Degludec in Patients with Type 2 Diabetes in China

Abstract

Authors

周. 黎 N. Yang Q. Luo M. Hu

Full Text Cite This Article
Back to Volume 22, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×